Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
100,428,408
-
Share change
-
+14,476,955
-
Total reported value
-
$67,260,619
-
Put/Call ratio
-
185%
-
Price per share
-
$0.6702
-
Number of holders
-
127
-
Value change
-
+$9,872,665
-
Number of buys
-
46
-
Number of sells
-
64
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2024
As of 31 Mar 2024 SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) had 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 100,428,408 shares of stock of the company.
Largest 10 holders included WASATCH ADVISORS LP, ARMISTICE CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA ADVISERS, LP.
This table shows 125 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.